Expression and influence of pentraxin-3, HbAlc and ApoA1/ApoB in serum of patients with acute myocardial infarction combined with diabetes mellitus type 2.
Increased Neutrophil elastase and proteinase 3 are closely associated with occurrence and severity of stroke and acute myocardial infarction in patients with type 2 diabetes mellitus.
[Venous thrombolysis with the recombinant human tissue-type plasminogen activator (rt-PA) during the first 3 hours following acute myocardial infarction. Controlled pilot study with placebo].
Defining and managing patients with non-ST-elevation myocardial infarction: Sorting through type 1 vs other types.
Cohen M, Visveswaran G.
Clin Cardiol. 2020 Mar;43(3):242-250. doi: 10.1002/clc.23308. Epub 2020 Jan 10.
Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials.
Keeley EC, Boura JA, Grines CL.
Lancet. 2003 Jan 4;361(9351):13-20. doi: 10.1016/S0140-6736(03)12113-7.
The Impact of Type of Acute Myocardial Infarction on Cardiac Patient Self-efficacy After Hospitalization.
Shajrawi AM, Al-Smadi AM, Ashour A, Momani A, Al-Akash HY, Granat M, Jones I.
Dimens Crit Care Nurs. 2022 Nov-Dec 01;41(6):295-304. doi: 10.1097/DCC.0000000000000547.
From Atherosclerotic Plaque to Myocardial Infarction-The Leading Cause of Coronary Artery Occlusion.
Młynarska E, Czarnik W, Fularski P, Hajdys J, Majchrowicz G, Stabrawa M, Rysz J, Franczyk B.
Int J Mol Sci. 2024 Jul 2;25(13):7295. doi: 10.3390/ijms25137295.
FSTL3 partially mediates the association of increased nonalcoholic fatty liver disease fibrosis risk with acute myocardial infarction in patients with type 2 diabetes mellitus.
Duan W, Shi R, Yang F, Zhou Z, Wang L, Huang Z, Zang S.
Cardiovasc Diabetol. 2023 Oct 30;22(1):297. doi: 10.1186/s12933-023-02024-x.
Acute Kidney Injury in Acute Myocardial Infarction and Its Outcome at 3 and 6 Months.
Kaur J, Bhardwaj N, Reddy S, D'Cruz S.
Saudi J Kidney Dis Transpl. 2023 Jul 1;34(4):297-304. doi: 10.4103/1319-2442.395445. Epub 2024 Feb 12.
Type 1, Type 2 Myocardial Infarction and Non-Ischemic Myocardial Injury-Opinion from the Front Lines.
Alpert JS, Jaffe AS, White HD, Thygesen KA.
Am J Med. 2022 Aug;135(8):935-938. doi: 10.1016/j.amjmed.2022.03.004. Epub 2022 Mar 25.
Timing of Recognition of Type A Acute Aortic Dissection in Acute Myocardial Infarction.
Saito Y, Ichihara S, Hashimoto O, Nakayama T, Sasaki H, Yumoto K, Oshima S, Tobaru T, Kushida S, Kanda J, Sakai Y, Okino S, Fukuzawa S, Abiko A, Itoh T, Nakamura Y, Nakashima T, Yasuda S, Goto K, Takebayashi H, Oshitomi T, Sakamoto T, Kojima S, Otsuka Y, Himi T, Inagaki Y, Yamaguchi J, Hagiya K, Nanasato M, Kobayashi Y.
Am J Cardiol. 2023 Nov 15;207:428-430. doi: 10.1016/j.amjcard.2023.09.012. Epub 2023 Oct 3.
Predictive value of type D personality for cardiac events in Chinese patients with acute myocardial infarction.
Li J, Wu W, Li N, Wang J, Zu L, Ye X.
BMC Cardiovasc Disord. 2023 Nov 14;23(1):556. doi: 10.1186/s12872-023-03598-w.
Nine-fold higher risk of acute myocardial infarction in subjects with type 1 diabetes compared to controls in Norway 1973-2017.
Saeed M, Stene LC, Ariansen I, Tell GS, Tapia G, Joner G, Skrivarhaug T.
Cardiovasc Diabetol. 2022 Apr 27;21(1):59. doi: 10.1186/s12933-022-01498-5.
